Related Experiment Video
Updated: Jun 7, 2026

07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy
Yasuyo Suzuki1, Kimiko Nakayama, Naohiro Hashimoto
1Laboratory of Research Resources, Research Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, Aichi, Japan.
The FEBS Journal
|October 28, 2010
Summary
Dentatorubral-pallidoluysian atrophy involves atrophin-1 (ATN1) with expanded polyglutamine (polyQ) tracts. A novel C-terminal fragment of ATN1 accumulates, playing a key role in neurodegeneration.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Dentatorubral-pallidoluysian atrophy (DRPLA) is a neurodegenerative disorder caused by polyglutamine (polyQ) expansion in the atrophin-1 (ATN1) protein.
- Nuclear accumulation of ATN1 and its fragments with expanded polyQ is implicated in DRPLA pathogenesis.
- The precise mechanisms governing ATN1 proteolytic processing and subsequent accumulation remain poorly understood.
Purpose of the Study:
- To investigate the proteolytic processing of ATN1 and elucidate the mechanisms behind polyQ-expanded ATN1 accumulation.
- To identify and characterize novel ATN1 fragments involved in DRPLA pathology.
Main Methods:
- Utilized COS-7 and Neuro2a cell lines expressing ATN1 with varying polyQ lengths.
- Employed immunocytochemical and biochemical analyses to study ATN1 fragment localization and accumulation.
- Investigated the role of caspases in ATN1 fragment processing.
Main Results:
- Identified a novel C-terminal ATN1 fragment containing a polyQ tract.
- Demonstrated selective accumulation of the mutant C-terminal fragment in cells and DRPLA patient brain tissues.
- Found that the mutant C-terminal fragment localizes to the cytoplasmic membrane/organelle and insoluble fractions.
- Observed enhanced accumulation of the C-terminal fragment upon caspase inhibition.
Conclusions:
- Proteolytic processing of ATN1 significantly influences the localization of its C-terminal fragments.
- The C-terminal ATN1 fragment plays a crucial role in the pathological accumulation of ATN1 in DRPLA.
- Targeting the processing or accumulation of this C-terminal fragment may offer therapeutic strategies for DRPLA.
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

